Talia Gutman , Dale Coghlan , Jonathan C. Craig , Chandana Guha , Allison Jaure , Shilpanjali Jesudason , Adeera Levin , David M. White , Javier Recabarren Silva , Anita van Zwieten , David Tunnicliffe , Andrea K. Viecelli , Germaine Wong , Armando Teixeira-Pinto , Siah Kim , Stephen McDonald , Carmel M. Hawley , Nicole Scholes-Robertson
{"title":"CKD研究中患者和护理人员参与的系统综述","authors":"Talia Gutman , Dale Coghlan , Jonathan C. Craig , Chandana Guha , Allison Jaure , Shilpanjali Jesudason , Adeera Levin , David M. White , Javier Recabarren Silva , Anita van Zwieten , David Tunnicliffe , Andrea K. Viecelli , Germaine Wong , Armando Teixeira-Pinto , Siah Kim , Stephen McDonald , Carmel M. Hawley , Nicole Scholes-Robertson","doi":"10.1016/j.ekir.2025.03.018","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Limited consumer involvement in chronic kidney disease (CKD) research may reduce its relevance, impact, and transferability into practice and policy. We aimed to describe the current landscape of consumer (patients with CKD and caregivers) involvement in published CKD research.</div></div><div><h3>Methods</h3><div>Electronic databases were searched to August 2023. Articles describing consumer involvement in CKD research were eligible. All text were imported into NVivo for line-by-line coding using descriptive synthesis of these domains: defining involvement, purpose of involvement, selection, stages of the research, resources, and evaluation.</div></div><div><h3>Results</h3><div>We included 106 articles that involved over 4500 consumers from 15 countries. Eighty-two articles (77%) defined consumer involvement, using 8 different terms. Forty-three articles (41%) addressed reasons for involving consumers in research. Consumers were predominantly identified through clinical or patient networks based on demographic or clinical characteristics. Those involved at higher levels (e.g., coresearcher/patient partner) often had medical or academic training. Consumers were rarely drivers or commissioners of research (<em>n</em> = 6, 6%) and were most likely to be involved as informants (<em>n</em> = 81, 76%) with limited decision-making power. Most articles described consumer involvement in priority setting (<em>n</em> = 48, 45%) and research design (<em>n</em> = 57, 53%) with less evidence of involvement in implementation (<em>n</em> = 28, 26%) and evaluation (<em>n</em> = 24, 22%). Barriers included limited resources (i.e., financial, logistical, or training) and the need for tailored solutions continue to exist. Consumer involvement resulted in increased recruitment and retention, richer data, and more useful outputs for end users.</div></div><div><h3>Conclusions</h3><div>Consumers were mostly involved in discrete activities with limited decision-making power. Increasing financial, logistical, and training resources for consumers may support more meaningful involvement. Ongoing evaluation of processes or impacts of consumer involvement, including consistent reporting, is needed to strengthen evidence and practice in CKD research.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"10 6","pages":"Pages 1657-1672"},"PeriodicalIF":5.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Systematic Review of Patient and Caregiver Involvement in CKD Research\",\"authors\":\"Talia Gutman , Dale Coghlan , Jonathan C. Craig , Chandana Guha , Allison Jaure , Shilpanjali Jesudason , Adeera Levin , David M. White , Javier Recabarren Silva , Anita van Zwieten , David Tunnicliffe , Andrea K. Viecelli , Germaine Wong , Armando Teixeira-Pinto , Siah Kim , Stephen McDonald , Carmel M. Hawley , Nicole Scholes-Robertson\",\"doi\":\"10.1016/j.ekir.2025.03.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Limited consumer involvement in chronic kidney disease (CKD) research may reduce its relevance, impact, and transferability into practice and policy. We aimed to describe the current landscape of consumer (patients with CKD and caregivers) involvement in published CKD research.</div></div><div><h3>Methods</h3><div>Electronic databases were searched to August 2023. Articles describing consumer involvement in CKD research were eligible. All text were imported into NVivo for line-by-line coding using descriptive synthesis of these domains: defining involvement, purpose of involvement, selection, stages of the research, resources, and evaluation.</div></div><div><h3>Results</h3><div>We included 106 articles that involved over 4500 consumers from 15 countries. Eighty-two articles (77%) defined consumer involvement, using 8 different terms. Forty-three articles (41%) addressed reasons for involving consumers in research. Consumers were predominantly identified through clinical or patient networks based on demographic or clinical characteristics. Those involved at higher levels (e.g., coresearcher/patient partner) often had medical or academic training. Consumers were rarely drivers or commissioners of research (<em>n</em> = 6, 6%) and were most likely to be involved as informants (<em>n</em> = 81, 76%) with limited decision-making power. Most articles described consumer involvement in priority setting (<em>n</em> = 48, 45%) and research design (<em>n</em> = 57, 53%) with less evidence of involvement in implementation (<em>n</em> = 28, 26%) and evaluation (<em>n</em> = 24, 22%). Barriers included limited resources (i.e., financial, logistical, or training) and the need for tailored solutions continue to exist. Consumer involvement resulted in increased recruitment and retention, richer data, and more useful outputs for end users.</div></div><div><h3>Conclusions</h3><div>Consumers were mostly involved in discrete activities with limited decision-making power. Increasing financial, logistical, and training resources for consumers may support more meaningful involvement. Ongoing evaluation of processes or impacts of consumer involvement, including consistent reporting, is needed to strengthen evidence and practice in CKD research.</div></div>\",\"PeriodicalId\":17761,\"journal\":{\"name\":\"Kidney International Reports\",\"volume\":\"10 6\",\"pages\":\"Pages 1657-1672\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney International Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468024925001615\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney International Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468024925001615","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Systematic Review of Patient and Caregiver Involvement in CKD Research
Introduction
Limited consumer involvement in chronic kidney disease (CKD) research may reduce its relevance, impact, and transferability into practice and policy. We aimed to describe the current landscape of consumer (patients with CKD and caregivers) involvement in published CKD research.
Methods
Electronic databases were searched to August 2023. Articles describing consumer involvement in CKD research were eligible. All text were imported into NVivo for line-by-line coding using descriptive synthesis of these domains: defining involvement, purpose of involvement, selection, stages of the research, resources, and evaluation.
Results
We included 106 articles that involved over 4500 consumers from 15 countries. Eighty-two articles (77%) defined consumer involvement, using 8 different terms. Forty-three articles (41%) addressed reasons for involving consumers in research. Consumers were predominantly identified through clinical or patient networks based on demographic or clinical characteristics. Those involved at higher levels (e.g., coresearcher/patient partner) often had medical or academic training. Consumers were rarely drivers or commissioners of research (n = 6, 6%) and were most likely to be involved as informants (n = 81, 76%) with limited decision-making power. Most articles described consumer involvement in priority setting (n = 48, 45%) and research design (n = 57, 53%) with less evidence of involvement in implementation (n = 28, 26%) and evaluation (n = 24, 22%). Barriers included limited resources (i.e., financial, logistical, or training) and the need for tailored solutions continue to exist. Consumer involvement resulted in increased recruitment and retention, richer data, and more useful outputs for end users.
Conclusions
Consumers were mostly involved in discrete activities with limited decision-making power. Increasing financial, logistical, and training resources for consumers may support more meaningful involvement. Ongoing evaluation of processes or impacts of consumer involvement, including consistent reporting, is needed to strengthen evidence and practice in CKD research.
期刊介绍:
Kidney International Reports, an official journal of the International Society of Nephrology, is a peer-reviewed, open access journal devoted to the publication of leading research and developments related to kidney disease. With the primary aim of contributing to improved care of patients with kidney disease, the journal will publish original clinical and select translational articles and educational content related to the pathogenesis, evaluation and management of acute and chronic kidney disease, end stage renal disease (including transplantation), acid-base, fluid and electrolyte disturbances and hypertension. Of particular interest are submissions related to clinical trials, epidemiology, systematic reviews (including meta-analyses) and outcomes research. The journal will also provide a platform for wider dissemination of national and regional guidelines as well as consensus meeting reports.